Viewing nowCombinationVersace 40/10mg
Telmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Samick Pharmaceutical Co., Ltd.

MFDS item code 201606771 · Approved 2016.11.25 · Insurance code 644003810
Treatment of essential hypertension not controlled with monotherapy
This medication helps effectively manage blood pressure when amlodipine or telmisartan alone is insufficient for patients with essential hypertension. It dilates blood vessels to lower blood pressure and reduce the burden on the heart, making it very useful for hypertension management. Furthermore, when used for an extended period, it maintains stable blood pressure levels and reduces the risk of complications. This treatment contributes to the prevention of cardiovascular diseases caused by hypertension. It is used to improve blood pressure management in patients with hypertension.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time every day (e.g., in the morning). Before administering this medicine, it is recommended to adjust the dose using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or telmisartan 40mg. - 80/5mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or this medicine 40/5mg. - 40/10mg: For patients whose blood pressure is not adequately controlled with amlodipine 10mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan in patients with mild or moderate hepatic impairment should not exceed 40 milligrams. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section ‘3. Patients requiring caution in administration’.) In patients aged 75 years and older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years and younger; therefore, its use is not recommended.
This medication should not be used during pregnancy, especially in the second and third trimesters, as it can pose serious risks to the fetus. If pregnancy is confirmed, the use of this medication should be discontinued immediately, and if necessary, replaced with other safe medications. Patients who are allergic to this medication or have certain liver, heart, or kidney diseases should not take it. It is contraindicated, particularly in patients with severe liver impairment, left ventricular outflow obstruction, heart shock, or unstable heart failure after acute myocardial infarction. Additionally, patients with diabetes or moderate to severe kidney impairment should not take this medication with aliskiren-containing products. Patients with primary hyperaldosteronism or certain heart valve diseases should use this medication cautiously. Patients with impaired liver function may experience delayed metabolism of this medication, necessitating caution. Patients with gastrointestinal disorders should be careful due to the risk of gastrointestinal bleeding. Caution is also required for patients with renal artery hypertension, patients on dialysis, and the elderly when taking this medication. This medication lowers blood pressure, which may lead to side effects such as hypotension, dizziness, and peripheral edema. While severe side effects are rare, symptoms like syncope or heart abnormalities may occur, so any unusual symptoms should be discussed with healthcare professionals immediately. Interactions may occur when this medication is taken with other antihypertensive drugs, so it is essential to inform about ongoing medications. Caution is particularly needed when taken with potassium supplements or medications containing potassium, as this medication can increase potassium levels. It is advisable not to use this medication while breastfeeding, and nursing mothers should avoid its use. Its safety and efficacy have not been sufficiently established for children and it is not recommended. Dosage for the elderly should be adjusted, and gradual increases are safer. In case of overdose, symptoms like hypotension, dizziness, and irregular heartbeats may occur, requiring immediate emergency treatment. This medication should be kept out of the reach of children and it is recommended to consume it immediately after opening. Caution is also advised when driving or operating machinery due to potential dizziness or drowsiness.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a container that blocks light and allows for proper air circulation. Additionally, it is best to store it at room temperature between 1°C and 30°C.
Biconvex oval double-shaped tablet with white to light yellow and pale blue color
30 tablets (10 tablets/PTP x 3), 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Samick Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.